Request for Covid-19 Impact Assessment of this Report
The United States OTC Anti-Infective Medications market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global OTC Anti-Infective Medications market, reaching US$ million by the year 2028. As for the Europe OTC Anti-Infective Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main OTC Anti-Infective Medications players cover GlaxoSmithKline, Merck, Pfizer, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Anti-Infective Medications market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Antifungals
Antiseptic
Antiparasitics
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Drug Stores
E-Commerce
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Anti-Infective Medications Market Size 2017-2028
2.1.2 OTC Anti-Infective Medications Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 OTC Anti-Infective Medications Segment by Type
2.2.1 Antifungals
2.2.2 Antiseptic
2.2.3 Antiparasitics
2.3 OTC Anti-Infective Medications Market Size by Type
2.3.1 OTC Anti-Infective Medications Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global OTC Anti-Infective Medications Market Size Market Share by Type (2017-2022)
2.4 OTC Anti-Infective Medications Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores
2.4.3 E-Commerce
2.5 OTC Anti-Infective Medications Market Size by Application
2.5.1 OTC Anti-Infective Medications Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global OTC Anti-Infective Medications Market Size Market Share by Application (2017-2022)
3 OTC Anti-Infective Medications Market Size by Player
3.1 OTC Anti-Infective Medications Market Size Market Share by Players
3.1.1 Global OTC Anti-Infective Medications Revenue by Players (2020-2022)
3.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2020-2022)
3.2 Global OTC Anti-Infective Medications Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OTC Anti-Infective Medications by Regions
4.1 OTC Anti-Infective Medications Market Size by Regions (2017-2022)
4.2 Americas OTC Anti-Infective Medications Market Size Growth (2017-2022)
4.3 APAC OTC Anti-Infective Medications Market Size Growth (2017-2022)
4.4 Europe OTC Anti-Infective Medications Market Size Growth (2017-2022)
4.5 Middle East & Africa OTC Anti-Infective Medications Market Size Growth (2017-2022)
5 Americas
5.1 Americas OTC Anti-Infective Medications Market Size by Country (2017-2022)
5.2 Americas OTC Anti-Infective Medications Market Size by Type (2017-2022)
5.3 Americas OTC Anti-Infective Medications Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Anti-Infective Medications Market Size by Region (2017-2022)
6.2 APAC OTC Anti-Infective Medications Market Size by Type (2017-2022)
6.3 APAC OTC Anti-Infective Medications Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe OTC Anti-Infective Medications by Country (2017-2022)
7.2 Europe OTC Anti-Infective Medications Market Size by Type (2017-2022)
7.3 Europe OTC Anti-Infective Medications Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC Anti-Infective Medications by Region (2017-2022)
8.2 Middle East & Africa OTC Anti-Infective Medications Market Size by Type (2017-2022)
8.3 Middle East & Africa OTC Anti-Infective Medications Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global OTC Anti-Infective Medications Market Forecast
10.1 Global OTC Anti-Infective Medications Forecast by Regions (2023-2028)
10.1.1 Global OTC Anti-Infective Medications Forecast by Regions (2023-2028)
10.1.2 Americas OTC Anti-Infective Medications Forecast
10.1.3 APAC OTC Anti-Infective Medications Forecast
10.1.4 Europe OTC Anti-Infective Medications Forecast
10.1.5 Middle East & Africa OTC Anti-Infective Medications Forecast
10.2 Americas OTC Anti-Infective Medications Forecast by Country (2023-2028)
10.2.1 United States OTC Anti-Infective Medications Market Forecast
10.2.2 Canada OTC Anti-Infective Medications Market Forecast
10.2.3 Mexico OTC Anti-Infective Medications Market Forecast
10.2.4 Brazil OTC Anti-Infective Medications Market Forecast
10.3 APAC OTC Anti-Infective Medications Forecast by Region (2023-2028)
10.3.1 China OTC Anti-Infective Medications Market Forecast
10.3.2 Japan OTC Anti-Infective Medications Market Forecast
10.3.3 Korea OTC Anti-Infective Medications Market Forecast
10.3.4 Southeast Asia OTC Anti-Infective Medications Market Forecast
10.3.5 India OTC Anti-Infective Medications Market Forecast
10.3.6 Australia OTC Anti-Infective Medications Market Forecast
10.4 Europe OTC Anti-Infective Medications Forecast by Country (2023-2028)
10.4.1 Germany OTC Anti-Infective Medications Market Forecast
10.4.2 France OTC Anti-Infective Medications Market Forecast
10.4.3 UK OTC Anti-Infective Medications Market Forecast
10.4.4 Italy OTC Anti-Infective Medications Market Forecast
10.4.5 Russia OTC Anti-Infective Medications Market Forecast
10.5 Middle East & Africa OTC Anti-Infective Medications Forecast by Region (2023-2028)
10.5.1 Egypt OTC Anti-Infective Medications Market Forecast
10.5.2 South Africa OTC Anti-Infective Medications Market Forecast
10.5.3 Israel OTC Anti-Infective Medications Market Forecast
10.5.4 Turkey OTC Anti-Infective Medications Market Forecast
10.5.5 GCC Countries OTC Anti-Infective Medications Market Forecast
10.6 Global OTC Anti-Infective Medications Forecast by Type (2023-2028)
10.7 Global OTC Anti-Infective Medications Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline OTC Anti-Infective Medications Product Offered
11.1.3 GlaxoSmithKline OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck OTC Anti-Infective Medications Product Offered
11.2.3 Merck OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer OTC Anti-Infective Medications Product Offered
11.3.3 Pfizer OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis OTC Anti-Infective Medications Product Offered
11.4.3 Novartis OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott OTC Anti-Infective Medications Product Offered
11.5.3 Abbott OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Abbott Main Business Overview
11.5.5 Abbott Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi OTC Anti-Infective Medications Product Offered
11.6.3 Sanofi OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb OTC Anti-Infective Medications Product Offered
11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bristol-Myers Squibb Main Business Overview
11.7.5 Bristol-Myers Squibb Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche OTC Anti-Infective Medications Product Offered
11.8.3 Roche OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 NanoViricides
11.9.1 NanoViricides Company Information
11.9.2 NanoViricides OTC Anti-Infective Medications Product Offered
11.9.3 NanoViricides OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 NanoViricides Main Business Overview
11.9.5 NanoViricides Latest Developments
11.10 Novabay Pharmaceuticals
11.10.1 Novabay Pharmaceuticals Company Information
11.10.2 Novabay Pharmaceuticals OTC Anti-Infective Medications Product Offered
11.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Novabay Pharmaceuticals Main Business Overview
11.10.5 Novabay Pharmaceuticals Latest Developments
11.11 Optimer Pharmaceuticals
11.11.1 Optimer Pharmaceuticals Company Information
11.11.2 Optimer Pharmaceuticals OTC Anti-Infective Medications Product Offered
11.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Optimer Pharmaceuticals Main Business Overview
11.11.5 Optimer Pharmaceuticals Latest Developments
11.12 Basilea Pharmaceutica
11.12.1 Basilea Pharmaceutica Company Information
11.12.2 Basilea Pharmaceutica OTC Anti-Infective Medications Product Offered
11.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Basilea Pharmaceutica Main Business Overview
11.12.5 Basilea Pharmaceutica Latest Developments
11.13 MerLion Pharma
11.13.1 MerLion Pharma Company Information
11.13.2 MerLion Pharma OTC Anti-Infective Medications Product Offered
11.13.3 MerLion Pharma OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 MerLion Pharma Main Business Overview
11.13.5 MerLion Pharma Latest Developments
12 Research Findings and Conclusion
Table 1. OTC Anti-Infective Medications Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Antifungals
Table 3. Major Players of Antiseptic
Table 4. Major Players of Antiparasitics
Table 5. OTC Anti-Infective Medications Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global OTC Anti-Infective Medications Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global OTC Anti-Infective Medications Market Size Market Share by Type (2017-2022)
Table 8. OTC Anti-Infective Medications Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global OTC Anti-Infective Medications Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global OTC Anti-Infective Medications Market Size Market Share by Application (2017-2022)
Table 11. Global OTC Anti-Infective Medications Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global OTC Anti-Infective Medications Revenue Market Share by Player (2020-2022)
Table 13. OTC Anti-Infective Medications Key Players Head office and Products Offered
Table 14. OTC Anti-Infective Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global OTC Anti-Infective Medications Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global OTC Anti-Infective Medications Market Size Market Share by Regions (2017-2022)
Table 19. Americas OTC Anti-Infective Medications Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas OTC Anti-Infective Medications Market Size Market Share by Country (2017-2022)
Table 21. Americas OTC Anti-Infective Medications Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas OTC Anti-Infective Medications Market Size Market Share by Type (2017-2022)
Table 23. Americas OTC Anti-Infective Medications Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas OTC Anti-Infective Medications Market Size Market Share by Application (2017-2022)
Table 25. APAC OTC Anti-Infective Medications Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC OTC Anti-Infective Medications Market Size Market Share by Region (2017-2022)
Table 27. APAC OTC Anti-Infective Medications Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC OTC Anti-Infective Medications Market Size Market Share by Type (2017-2022)
Table 29. APAC OTC Anti-Infective Medications Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC OTC Anti-Infective Medications Market Size Market Share by Application (2017-2022)
Table 31. Europe OTC Anti-Infective Medications Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe OTC Anti-Infective Medications Market Size Market Share by Country (2017-2022)
Table 33. Europe OTC Anti-Infective Medications Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe OTC Anti-Infective Medications Market Size Market Share by Type (2017-2022)
Table 35. Europe OTC Anti-Infective Medications Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe OTC Anti-Infective Medications Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa OTC Anti-Infective Medications Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa OTC Anti-Infective Medications Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa OTC Anti-Infective Medications Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa OTC Anti-Infective Medications Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa OTC Anti-Infective Medications Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa OTC Anti-Infective Medications Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of OTC Anti-Infective Medications
Table 44. Key Market Challenges & Risks of OTC Anti-Infective Medications
Table 45. Key Industry Trends of OTC Anti-Infective Medications
Table 46. Global OTC Anti-Infective Medications Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global OTC Anti-Infective Medications Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global OTC Anti-Infective Medications Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global OTC Anti-Infective Medications Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global OTC Anti-Infective Medications Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global OTC Anti-Infective Medications Market Size Market Share Forecast by Application (2023-2028)
Table 52. GlaxoSmithKline Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 53. GlaxoSmithKline OTC Anti-Infective Medications Product Offered
Table 54. GlaxoSmithKline OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. GlaxoSmithKline Main Business
Table 56. GlaxoSmithKline Latest Developments
Table 57. Merck Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 58. Merck OTC Anti-Infective Medications Product Offered
Table 59. Merck Main Business
Table 60. Merck OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Merck Latest Developments
Table 62. Pfizer Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 63. Pfizer OTC Anti-Infective Medications Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Pfizer Latest Developments
Table 67. Novartis Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 68. Novartis OTC Anti-Infective Medications Product Offered
Table 69. Novartis Main Business
Table 70. Novartis OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novartis Latest Developments
Table 72. Abbott Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 73. Abbott OTC Anti-Infective Medications Product Offered
Table 74. Abbott Main Business
Table 75. Abbott OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Abbott Latest Developments
Table 77. Sanofi Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 78. Sanofi OTC Anti-Infective Medications Product Offered
Table 79. Sanofi Main Business
Table 80. Sanofi OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Sanofi Latest Developments
Table 82. Bristol-Myers Squibb Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 83. Bristol-Myers Squibb OTC Anti-Infective Medications Product Offered
Table 84. Bristol-Myers Squibb Main Business
Table 85. Bristol-Myers Squibb OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Bristol-Myers Squibb Latest Developments
Table 87. Roche Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 88. Roche OTC Anti-Infective Medications Product Offered
Table 89. Roche Main Business
Table 90. Roche OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Roche Latest Developments
Table 92. NanoViricides Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 93. NanoViricides OTC Anti-Infective Medications Product Offered
Table 94. NanoViricides Main Business
Table 95. NanoViricides OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. NanoViricides Latest Developments
Table 97. Novabay Pharmaceuticals Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 98. Novabay Pharmaceuticals OTC Anti-Infective Medications Product Offered
Table 99. Novabay Pharmaceuticals Main Business
Table 100. Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Novabay Pharmaceuticals Latest Developments
Table 102. Optimer Pharmaceuticals Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 103. Optimer Pharmaceuticals OTC Anti-Infective Medications Product Offered
Table 104. Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Optimer Pharmaceuticals Main Business
Table 106. Optimer Pharmaceuticals Latest Developments
Table 107. Basilea Pharmaceutica Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 108. Basilea Pharmaceutica OTC Anti-Infective Medications Product Offered
Table 109. Basilea Pharmaceutica Main Business
Table 110. Basilea Pharmaceutica OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Basilea Pharmaceutica Latest Developments
Table 112. MerLion Pharma Details, Company Type, OTC Anti-Infective Medications Area Served and Its Competitors
Table 113. MerLion Pharma OTC Anti-Infective Medications Product Offered
Table 114. MerLion Pharma Main Business
Table 115. MerLion Pharma OTC Anti-Infective Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. MerLion Pharma Latest Developments
List of Figures
Figure 1. OTC Anti-Infective Medications Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global OTC Anti-Infective Medications Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global OTC Anti-Infective Medications Market Size Market Share by Type in 2021
Figure 7. OTC Anti-Infective Medications in Hospital Pharmacies
Figure 8. Global OTC Anti-Infective Medications Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. OTC Anti-Infective Medications in Drug Stores
Figure 10. Global OTC Anti-Infective Medications Market: Drug Stores (2017-2022) & ($ Millions)
Figure 11. OTC Anti-Infective Medications in E-Commerce
Figure 12. Global OTC Anti-Infective Medications Market: E-Commerce (2017-2022) & ($ Millions)
Figure 13. Global OTC Anti-Infective Medications Market Size Market Share by Application in 2021
Figure 14. Global OTC Anti-Infective Medications Revenue Market Share by Player in 2021
Figure 15. Global OTC Anti-Infective Medications Market Size Market Share by Regions (2017-2022)
Figure 16. Americas OTC Anti-Infective Medications Market Size 2017-2022 ($ Millions)
Figure 17. APAC OTC Anti-Infective Medications Market Size 2017-2022 ($ Millions)
Figure 18. Europe OTC Anti-Infective Medications Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa OTC Anti-Infective Medications Market Size 2017-2022 ($ Millions)
Figure 20. Americas OTC Anti-Infective Medications Value Market Share by Country in 2021
Figure 21. Americas OTC Anti-Infective Medications Consumption Market Share by Type in 2021
Figure 22. Americas OTC Anti-Infective Medications Market Size Market Share by Application in 2021
Figure 23. United States OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC OTC Anti-Infective Medications Market Size Market Share by Region in 2021
Figure 28. APAC OTC Anti-Infective Medications Market Size Market Share by Application in 2021
Figure 29. China OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 33. India OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe OTC Anti-Infective Medications Market Size Market Share by Country in 2021
Figure 36. Europe OTC Anti-Infective Medications Market Size Market Share by Type in 2021
Figure 37. Europe OTC Anti-Infective Medications Market Size Market Share by Application in 2021
Figure 38. Germany OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 39. France OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa OTC Anti-Infective Medications Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa OTC Anti-Infective Medications Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa OTC Anti-Infective Medications Market Size Market Share by Application in 2021
Figure 46. Egypt OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country OTC Anti-Infective Medications Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 52. APAC OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 53. Europe OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 55. United States OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 56. Canada OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 57. Mexico OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 58. Brazil OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 59. China OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 60. Japan OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 61. Korea OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 63. India OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 64. Australia OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 65. Germany OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 66. France OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 67. UK OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 68. Italy OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 69. Russia OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 70. Spain OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 71. Egypt OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 72. South Africa OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 73. Israel OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 74. Turkey OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries OTC Anti-Infective Medications Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...